BALCX
Price
$35.36
Change
-$0.31 (-0.87%)
Updated
Jun 13 closing price
Net Assets
244.39B
DBALX
Price
$13.44
Change
-$0.05 (-0.37%)
Updated
Jun 13 closing price
Net Assets
252.99M
Interact to see
Advertisement

BALCX vs DBALX

Header iconBALCX vs DBALX Comparison
Open Charts BALCX vs DBALXBanner chart's image
American Funds American Balanced C
Price$35.36
Change-$0.31 (-0.87%)
VolumeN/A
Net Assets244.39B
Davenport Balanced Income
Price$13.44
Change-$0.05 (-0.37%)
VolumeN/A
Net Assets252.99M
BALCX vs DBALX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BALCX vs. DBALX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Buy and DBALX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 244B vs. DBALX (253M). DBALX pays higher dividends than BALCX: DBALX (2.51) vs BALCX (1.24). BALCX was incepted earlier than DBALX: BALCX (24 years) vs DBALX (9 years). BALCX (1.31) is less costly to investors than DBALX (0.93). DBALX (45.00) and BALCX (44.00) have comparable annual turnover. BALCX has a lower initial minimum investment than DBALX: BALCX (250) vs DBALX (5000). DBALX annual gain was more profitable for investors over the last year : 7.65 vs. BALCX (4.49). DBALX return over 5 years is better than : 36.44 vs. BALCX (34.15).
BALCXDBALXBALCX / DBALX
Total Expense Ratio1.310.93141%
Annual Report Gross Expense Ratio1.310.93141%
Fund Existence24 years9 years-
Gain YTD4.1214.28596%
Front LoadN/AN/A-
Min. Initial Investment25050005%
Min. Initial Investment IRAN/AN/A-
Net Assets244B253M96,443%
Annual Yield % from dividends1.242.5149%
Returns for 1 year4.497.6559%
Returns for 3 years30.1316.35184%
Returns for 5 years34.1536.4494%
Returns for 10 years51.38N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HWKN135.772.72
+2.04%
Hawkins
JAZZ108.50-1.79
-1.63%
Jazz Pharmaceuticals plc
CTO18.00-0.47
-2.54%
CTO Realty Growth
FI163.02-5.00
-2.98%
Fiserv
CNTX0.63-0.02
-3.56%
Context Therapeutics